PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Войти

Зарегистрироваться
Забыли пароль?

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20170803 131930
20180131 165349
20170803 193720
20170731 192225
20180816 164319
IMG-20170807-WA0030
  • FDA Roundup: May 26, 2023
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
  • Immune Globulin Hypersensitivity Reactions: Root Causes and Mitigation; Public Workshop - 03/30/2023
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-05-26 By FDA
  • Application Submissions Guidances
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-05-26 By FDA
  • Rare Disease Endpoint Advancement Pilot Program Frequently Asked Questions
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
  • FDA Updating Warnings to Improve Safe Use of Prescription Stimulants Used to Treat ADHD and Other Conditions.
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
  • An Update on Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR) - 05/24/2023
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
  • CDER Small Business & Industry Assistance (SBIA)
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
  • Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Cystinosis, Date of authorisation: 05/09/2013, Revision: 16, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-05-26
  • We Are Hiring
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
  • Abbreviated New Drug Application (ANDA)
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
  • FDA updates on hand sanitizers consumers should not use
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
  • CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
  • Summary of opinion: Opdivo,nivolumab, 25/05/2023, Positive
    Source: EMA - New medicines: human Published on 2023-05-26
  • Summary of opinion: Pylclari,piflufolastat (18F), 25/05/2023, Positive
    Source: EMA - New medicines: human Published on 2023-05-26
  • Summary of opinion: Ztalmy,ganaxolone, 26/05/2023, Positive
    Source: EMA - New medicines: human Published on 2023-05-26
Предыдущие записи
Тема: Scaffold от Danny Cooper.